Medtronic 8-K 2006
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 2, 2006
(Exact name of Registrant as Specified in its Charter)
(State or Other Jurisdiction of Incorporation)
710 Medtronic Parkway
Minneapolis, Minnesota 55432
(Address of Principal Executive Offices and Zip Code)
(Registrants telephone number, including area code)
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
TABLE OF CONTENTS
Item 2.02. Results of Operations and Financial Condition
On August 2, 2006, Medtronic, Inc. issued the press release furnished herewith as Exhibit 99.1 regarding CMS in-patient reimbursement decision and preliminary first quarter revenues.
Item 9.01. Financial Statements and Exhibits.
Exhibit 99.1 Press release dated August 2, 2006.
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Form 8-K Current Report